BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 11866271)

  • 21. Evidence that hereditary pancreatitis is genetically heterogeneous disorder.
    Ravnik-Glavac M; Dean M; di Sant'Agnese P; Chernick M; Kozelj M; Krizman I; Glavac D
    Pflugers Arch; 2000; 439(3 Suppl):R50-2. PubMed ID: 10653140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis.
    Férec C; Raguénès O; Salomon R; Roche C; Bernard JP; Guillot M; Quéré I; Faure C; Mercier B; Audrézet MP; Guillausseau PJ; Dupont C; Munnich A; Bignon JD; Le Bodic L
    J Med Genet; 1999 Mar; 36(3):228-32. PubMed ID: 10204851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis.
    Creighton JE; Lyall R; Wilson DI; Curtis A; Charnley RM
    Br J Surg; 2000 Feb; 87(2):170-5. PubMed ID: 10671922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?
    Felderbauer P; Klein W; Bulut K; Ansorge N; Dekomien G; Werner I; Epplen JT; Schmitz F; Schmidt WE
    Scand J Gastroenterol; 2006 Mar; 41(3):343-8. PubMed ID: 16497624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis of hereditary pancreatitis.
    Chen JM; Ferec C
    Eur J Hum Genet; 2000 Jul; 8(7):473-9. PubMed ID: 10909845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in hereditary pancreatitis.
    Dasouki MJ; Cogan J; Summar ML; Neblitt W; Foroud T; Koller D; Phillips JA
    Am J Med Genet; 1998 Apr; 77(1):47-53. PubMed ID: 9557894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary pancreatitis].
    Jørgensen MT; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2003 Jan; 165(5):447-51. PubMed ID: 12599840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
    Weiss FU; Simon P; Bogdanova N; Mayerle J; Dworniczak B; Horst J; Lerch MM
    Gut; 2005 Oct; 54(10):1456-60. PubMed ID: 15987793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
    Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S
    Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisite mutations of the PRSS1 gene in a Chinese patient with chronic pancreatitis.
    Liu QC; Gao F; Cheng ZJ; Ou QS
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):331-2. PubMed ID: 18522894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
    Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
    Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serine protease inhibitor Kazal type 1 mutations and pancreatitis.
    Schneider A
    Gastroenterol Clin North Am; 2004 Dec; 33(4):789-806. PubMed ID: 15528018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients.
    Gomez-Lira M; Bonamini D; Castellani C; Unis L; Cavallini G; Assael BM; Pignatti PF
    Eur J Hum Genet; 2003 Jul; 11(7):543-6. PubMed ID: 12825076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the cationic trypsinogen in hereditary pancreatitis.
    Teich N; Mössner J; Keim V
    Hum Mutat; 1998; 12(1):39-43. PubMed ID: 9633818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis.
    Perri F; Piepoli A; Stanziale P; Merla A; Zelante L; Andriulli A
    Eur J Hum Genet; 2003 Sep; 11(9):687-92. PubMed ID: 12939655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
    Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
    Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.
    Witt H; Luck W; Hennies HC; Classen M; Kage A; Lass U; Landt O; Becker M
    Nat Genet; 2000 Jun; 25(2):213-6. PubMed ID: 10835640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local clustering of PRSS1 R122H mutations in hereditary pancreatitis patients from Northern Germany.
    Weiss FU; Zenker M; Ekici AB; Simon P; Mayerle J; Lerch MM
    Am J Gastroenterol; 2008 Oct; 103(10):2585-8. PubMed ID: 18702646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
    Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
    Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.